Study: TranS1 spine surgery leads to complications down the roadMass Device… The return on investment of administrative simplification · App-solute adherence: Using mobile technology to prevent transplant rejection · Leukemia talks to i…
Key Function of Protein Discovered for Obtaining Blood Stem Cells as Source …Science Daily (press release)Researchers Find Way to Help Donor Adult Blood Stem Cells Overcome Transplant Rejection (Aug. 4, 2011) — Findings may suggest new strategies f…
US Patents Awarded to Inventors in Washington (July 24)Equities.com… disease (GVHD), cutaneous T cell lymphoma (CTCL), Sjogren's syndrome, glomerulonephritis, IgA nephropathy, graft versous host disease, transplant rejection, atopic dermatitis, a…
Prostate cancer: Intuitive Surgical CEO Guthart on testing and "watchful waiting"Mass Device… The return on investment of administrative simplification · App-solute adherence: Using mobile technology to prevent transplant rejection &…
Legal: Bard loses 1st of transvaginal mesh patient injury lawsuitsMass Device… The return on investment of administrative simplification · App-solute adherence: Using mobile technology to prevent transplant rejection · Leukemia talks to…
Lanx loses bid to toss NuVasive's poaching lawsuitMass DeviceLessons from EKG class · Hospital disaster planning · The return on investment of administrative simplification · App-solute adherence: Using mobile technology to pre…
Wright Medical sought to block Smith & Nephew's metal-on-metal hip implantMass DeviceLessons from EKG class · Hospital disaster planning · The return on investment of administrative simplification · App-solute adherence: Us…
The Healthcare Short Sales That Never FitTheStreet.comJohnson & Johnson's(JNJ) Orthoclone OKT3 (known chemically as muromonab) received FDA approval in 1986 for the prevention of acute transplant rejection, but the technology relied solely on m…
Drs. Bruce Rosengard and Sanuj Ravindran Join The Medicines Company New …Healthcare Global (press release)Dr. Rosengard started his career at The University of Pennsylvania, where he performed the first combined heart-lung transplant at that institut…
Thermo Fisher Scientific to purchase One LambdaZenopaThe newly purchased company was founded in 1984 and offers diagnostic tests for use in determining the compatibility of donors and recipients pre-transplant, as well as to detect the presence of anti…